September is Prostate Cancer Awareness Month.
Prostate-specific antigen (PSA) screening and active surveillance play an important role in managing low-risk disease. Join Jay Bishoff, MD, Board Certified Urologist, and James Hendricks, MD, Board Certified Urologist, as they explore prostate cancer screening and the importance of personalized approaches based on individual risk factors including age, family history and ethnicity. Learn about the benefits of PSA testing and informed decision-making, in consultation with your physician.
Presented as part of the Selby Dunham Community Lecture Series.